• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

  • — 27 Feb, 2008
AudioMedica News
AudioMedica News
Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
00:00 /
RSS Feed
Share
Link
Embed
Timothy Illidge
Timothy Illidge

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
TIMOTHY ILLIDGE, Christie Hospital, Manchester
Radioconjugated antibodies are showing great promise for treating follicular lymphoma which has failed chemotherapy combined with rituximab. That’s according to Tim Illidge who told the Paris conference that tositumomab and ibritumomab tiuxetan have already proved effective. He explained to Peter Goodwin why he thinks the latest data look promising.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080227_timothy_illidge.mp3]

You may also like...

  • Audio Journal of Hematologic Malignancy, Volume 2 Number 1 Audio Journal of Hematologic Malignancy, Volume 2 Number 1 8 Jan, 2006
  • Community-Associated MRSA: Public Housing, Jail: Risks? Community-Associated MRSA: Public Housing, Jail: Risks? 4 Jan, 2006
  • Audio Journal of Medicine – reporting from Annual Meeting of the European Society of Human Reproduction and Embryology, Prague, 18th – 21st June, 2006 Audio Journal of Medicine – reporting from Annual Meeting of the European Society of Human Reproduction and Embryology, Prague, 18th – 21st June, 2006 19 Jun, 2006
  • Statins Protect Heart Patients from Sepsis Statins Protect Heart Patients from Sepsis 14 Feb, 2006
  • Previous story “Total Therapy” Possible Cure For Multiple Myeloma?
  • Next story Audio Journal of Oncology in Advance – March 1st, 2008
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • New Front Line Standard for Older Patients with Chronic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • General Medicine
  • Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.